NOVAMETRIX MEDICAL SYSTEMS INC.
			Consolidated Statements of Operations
				(Unaudited)
					  (000's)
							   Quarter Ended
						   07/28/96	07/30/95
 Revenue					   $ 6,422	$ 6,080
Costs and Expenses:
 Cost of products sold			   2,738	  2,590
 Research and product development		799	    685